PET-Dual Energy CT (PET-DECT) is an advanced cancer imaging technology that combines PET’s functional mapping with dual-energy CT’s detailed structural and tissue analysis. PET identifies areas of high metabolic activity using radioactive tracers, highlighting cancer cells as “hot spots,” while dual-energy CT distinguishes tissue types and contrast uptake for precise anatomical detail.
By merging these strengths, PET-DECT improves tumor detection, differentiates benign from malignant lesions, and enhances visualization of vascular tumors, even when small or difficult to distinguish from normal tissue. It can reduce radiation exposure by generating virtual non-contrast images and provides more accurate staging by detecting nodal and distant metastases often missed on conventional scans.
PET-DECT also enables early assessment of treatment response, measuring metabolic changes with PET and vascular changes with dual-energy CT. This allows oncologists to evaluate therapy effectiveness within weeks of initiation. Emerging methods aim to integrate dual-energy imaging into existing PET/CT systems, promising broader adoption and more personalized cancer care.